|Bid||6.00 x 1400|
|Ask||7.46 x 2200|
|Day's Range||6.40 - 6.69|
|52 Week Range||4.01 - 22.43|
|Beta (5Y Monthly)||2.65|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Good morning, and thank you for joining us for Neuronetics' second-quarter 2021 conference call. Joining me on today's call are Neuronetics' president and chief executive officer, Keith Sullivan, and Chief Financial OfficerSteve Furlong. Before we begin I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to our business, strategy, financial and revenue guidance, the impact of COVID-19, and other operational issues and metrics.
Neuronetics (STIM) delivered earnings and revenue surprises of -20.83% and -3.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Neuronetics (STIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.